Middleton & Co’s Boston Scientific BSX Stock Holding History

Middleton & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Buy	42,397 +18,640	+78%	+$1.01M	0.19%	79
2026 Q1	$1.49M	Buy	+23,757	New	+$1.9M	0.17%	83

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Middleton & Co's BSX Position: Q2 2026 in Review

Middleton & Co increased its Boston Scientific (BSX) stake by 78% in Q2 2026, buying an estimated $1.01M and bringing the position to 42,397 shares worth $1.81M. The position accounts for 0.19% of the portfolio, ranked #79.

Middleton & Co first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Middleton & Co held 42,397 shares of Boston Scientific worth $1.81M as of Q2 2026.
Middleton & Co bought 18,640 Boston Scientific shares in Q2 2026, an estimated $1.01M.
Boston Scientific made up 0.19% of Middleton & Co's portfolio in Q2 2026, its #79 holding.
Middleton & Co first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Middleton & Co's 13F filing for Q2 2026, filed 10 Aug 2026.